These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 11364855)
1. Improved but not new. Vazquez E Posit Aware; 1997; 8(6):19. PubMed ID: 11364855 [TBL] [Abstract][Full Text] [Related]
2. Soft gel saquinavir has high exposure. AIDS Alert; 1997 Dec; 12(12):143-4. PubMed ID: 11364835 [TBL] [Abstract][Full Text] [Related]
3. New formulation of saquinavir (Fortovase) is more effective. Tam CW Fac Notes (New Orleans La); 1998; 10(2):11. PubMed ID: 11365126 [TBL] [Abstract][Full Text] [Related]
4. Potent new AIDS drugs underscore promise of combination therapy. AIDS Alert; 1996 Jan; 11(1):1-4. PubMed ID: 11363225 [TBL] [Abstract][Full Text] [Related]
6. Data in from first head-to-head protease inhibitor. AIDS Patient Care STDS; 1998 Apr; 12(4):317. PubMed ID: 11361961 [No Abstract] [Full Text] [Related]
7. Double protease inhibitor regimens with amprenavir show promise. AIDS Patient Care STDS; 1998 Apr; 12(4):317-8. PubMed ID: 11361962 [No Abstract] [Full Text] [Related]
8. Anti-retroviral therapy in HIV-infected patients: in vitro effects of AZT and saquinavir on the response of CD4 and CD8 lymphocytes to interleukin-7. Beq S; Bugault F; Colle JH; Lambotte O; Delfraissy JF; Thèze J Eur Cytokine Netw; 2005 Dec; 16(4):293-9. PubMed ID: 16464744 [TBL] [Abstract][Full Text] [Related]
9. Why the old saquinavir (Invirase) may be bad for your health. Vazquez E Posit Aware; 1997; 8(4):28-31. PubMed ID: 11364485 [TBL] [Abstract][Full Text] [Related]
11. Saquinavir (Invirase): first protease inhibitor approved--reimbursement, information hotline numbers. James JS AIDS Treat News; 1995 Dec; (no 237):1-2. PubMed ID: 11363073 [TBL] [Abstract][Full Text] [Related]
12. New saquinavir formula more potent than original. Bartnof HS BETA; 1997 Sep; ():45. PubMed ID: 11364701 [TBL] [Abstract][Full Text] [Related]
13. Nelfinavir - major trial results at retroviruses conference. AIDS Treat News; 1997 Feb; (No 265):3-4. PubMed ID: 11364240 [TBL] [Abstract][Full Text] [Related]
14. Lamivudine (3TC) approved for combination use with AZT. James JS AIDS Treat News; 1995 Dec; (no 236):1-5. PubMed ID: 11363049 [TBL] [Abstract][Full Text] [Related]
16. No tease this time--pros and cons of a long-awaited anti-HIV drug. Chang HE Posit Aware; 1996; 7(1):18-20. PubMed ID: 11363118 [TBL] [Abstract][Full Text] [Related]
17. FDA approves 2 new protease inhibitors: ritonavir (Norvir) and Crixivan (Indinavir sulfate). Food and Drug Administration. Schouten JT STEP Perspect; 1996; 8(1):7-8. PubMed ID: 11363592 [TBL] [Abstract][Full Text] [Related]
18. The efficacy of combined zidovudine and lamivudine compared with that of combined zidovudine, lamivudine and nelfinavir in asymptomatic and early symptomatic HIV-infected children. Moolasart P; Likanonsakul S Southeast Asian J Trop Med Public Health; 2002 Jun; 33(2):280-7. PubMed ID: 12236426 [TBL] [Abstract][Full Text] [Related]
19. FDA triple header. Food and Drug Administration. Smart T GMHC Treat Issues; 1995 Nov; 9(11):1-3. PubMed ID: 11362986 [TBL] [Abstract][Full Text] [Related]